NeXtGen Biologics and Lovell Government Services Partner To Bring Innovative Advanced Wound Care Technology to Federal Healthcare Systems (Globe Newswire)
UF Innovate | Accelerate resident client NeXtGen™ Biologics has partnered with Lovell® Government Services to expand access to its advanced wound care technologies across federal healthcare systems, including the Veterans Health Administration (VHA), the Military Health System (MHS), and the Indian Health Service (IHS).
NeXtGen Biologics Successfully Completes First FDA Audit With Zero 483 Observations (Globe Newswire)
UF Innovate | Accelerate resident client NeXtGen Biologics announced the successful completion of a two-day inspection by the U.S. Food and Drug Administration (FDA).
iOncologi Secures Foundational U.S. Patent As Landmark Studies Link COVID19 mRNA Vaccines to Improved Survival With Cancer Immunotherapy (Bio Space))
UF startup iOncologi, Inc. announced that USPTO has granted a U.S. patent for a novel method using RNA-based formulations to enhance tumor responsiveness to immune checkpoint inhibitor (ICI) therapy.
NeXtGen Biologics Announces Issuance of a Third New Patent Covering Axolotl-Derived Technology (Globe Newswire)
UF Innovate | Accelerate resident client NeXtGen Biologics has announced the issuance of its third U.S. patent, part of a broader portfolio of U.S. and international patents focused on extracellular matrix components derived from a highly regenerative, non-mammalian species known as the axolotl, a type of urodele amphibian.
Oragenics Announces Strategic Partnership With Receptor.AI To Accelerate Pipeline Development (Oragenics)
UF Innovate | Accelerate graduate Oragenics announced a strategic collaboration with Receptor.AI, an artificial intelligence-driven drug profiling company, to accelerate the potential development of an expanded pharmaceutical-candidate portfolio for potential conditions affecting brain health.
Tech Tuesday: University of Florida Lab Diagnoses and Removes Viruses Through Genome Editing (WCJB TV20)
In this week’s Tech Tuesday, UF Innovate highlights CasNx, a company that uses CRISPR-based technologies for diagnostics and to genome-edit donor organs before transplant.
Solid Biosciences Announces Licensing Agreement with Kinea Bio for the Use of Proprietary Next-Generation Capsid AAV-SLB101 (Solid Biosciences)
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced a non-exclusive worldwide license and collaboration agreement with Kinea Bio for the use of Solid’s proprietary, next-generation capsid, AAV-SLB101.
Outsmarting Old Cells (UF Pharmacy)
UF researcher Lina Cui has studied cellular-level biological changes associated with aging through Senotrac Biotechnology, a UF Innovate | Accelerate client company.
Nasser Nassiri Koopaei Is on a Mission to Address Unmet Medical Needs With His Biotechnology Startup (UF Pharmacy)
UF researcher Nasser Nassiri Koopaei has been working to transform his research on stem cell-derived extracellular vesicles for targeted drug delivery through his biotechnology startup, EriVan Bio, a UF startup.
NysnoBio Publishes in Nature Parkinson’s Journal (NysnoBio)
UF Innovate | Accelerate client NysnoBio, with the support of Aligning Science Across Parkinson’s (ASAP) through the Michael J. Fox Foundation for Parkinson’s Research (MJFF), announces publication of studies to understand how PD mutations drive cellular phenotypes.